Status:
WITHDRAWN
Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore
Lead Sponsor:
Montefiore Medical Center
Conditions:
COVID
Coronavirus
Eligibility:
All Genders
18-99 years
Phase:
PHASE2
Brief Summary
Given the high prevalence of COVID19 illness (both SARS-CoV-2 RT-PCR confirmed and highly suspect cases) among healthcare workers (HCW) within the Montefiore Health System (MHS), hydroxychloroquine (H...
Eligibility Criteria
Inclusion
- Symptomatic with COVID illness (either RT-PCR test confirmed or highly suspect clinical symptoms)
- Call into office within the first 7 days of illness
- Have any of the following high risk conditions:
- Age \>60
- HTN, CAD, or chronic heart disease
- Diabetes
- Chronic kidney disease
- Chronic lung disease
- Active or recent chemotherapy for malignancy
- Organ transplant
- Taking Immune-suppressing medications
- HIV with CD4 \<200 cells/mm3
- Experiencing at least one of the following high risk symptoms:
- Severe cough
- Fever 100.0F or greater
- Diarrhea
- Shortness of Breath
- Hypoxia
Exclusion
- • HCW not meeting high-risk criteria or those with a contraindication to HCQ will not be offered HCQ
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04350450
Start Date
April 1 2020
End Date
August 1 2020
Last Update
May 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Montefiore Medical Center
The Bronx, New York, United States, 10467